BraveCX

K223754

Bering Ltd · cleared 2023-11-09 · product code QFM · Radiology

Premarket evidence — what FDA accepted

Device typesamd
source quote (p.3)
BraveCX is a radiological computer-assisted triage and notification software that analyzes adult (≥18 years old) chest X-ray images for the presence of pre-specified suspected critical findings (pleural effusion and/or pneumothorax).
AlgorithmDeep Learning Artificial Intelligence (AI) software
source quote (p.9)
BraveCX is a Deep Learning Artificial Intelligence (AI) software that was trained to detect pleural effusion and pneumothorax in chest X-Ray images.
Adaptive (vs locked)FDA source did not state this
PCCPFDA source did not state this
Cybersecurity addressedFDA source did not state this

Validation studies (2)

Retrospective clinical

n=2,596 cases · 14 site(s)

Retrospective clinical

n=2,981 cases · 3 site(s)

standards: IEC 62304

Reported performance (7 observations)

sensitivity0.9262CI 90.67%-94.27%
source quote (p.14)
Sensitivity 92.62% (95% CI:90.67%-94.27%)
specificity0.9811CI 97.33%-98.71%
source quote (p.14)
Specificity 98.11% (97.33%-98.71%).
aurocas written: “auc0.988CI 0.9885-0.9887
source quote (p.14)
ROC AUC 0.988 (95% CI:0.9885-0.9887)
aurocas written: “ROC AUC (Pneumothorax)0.972CI 0.9727-0.9729
source quote (p.14)
ROC AUC 0.972 (95% CI:0.9727-0.9729)
sensitivityas written: “Sensitivity (Pneumothorax)0.9338CI 92.23%-94.40%
source quote (p.14)
Sensitivity 93.38% (95% CI:92.23%-94.40%)
specificityas written: “Specificity (Pneumothorax)0.9727CI 96.49%-97.92%
source quote (p.14)
Specificity 97.27% (96.49%-97.92%).
time_to_resultas written: “Time-to-notification10.4CI 4.2-10.41s
source quote (p.15)
Time-to-notification of BraveCX was 4.8 seconds-10.4 seconds (95% CI: 4.2-10.41s) for simultaneous prediction of Pleural Effusion and Pneumothorax.

Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.

Predicate network

Postmarket — what happened after clearance

0
recalls in product code, 24mo
0
MAUDE reports in code, 12mo
vs code's own 3-yr baseline
0
drift signals on this device

Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.

Reimbursement — how devices like this got paid

Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).

RIGOR™ Precedent · public FDA/CMS data · descriptive decision-support, not regulatory or reimbursement advice. Share this page: radar.healthai.com/precedent/device/K223754